Literature DB >> 17026806

Stromal-epithelial interaction in prostate cancer progression.

Leland W K Chung1, Wen-Chin Huang, Shian-Ying Sung, Daqing Wu, Valerie Odero-Marah, Takeo Nomura, Katsumi Shigemura, Tohru Miyagi, Seogil Seo, Chumeng Shi, Joe Molitierno, James Elmore, Cynthia Anderson, Shuji Isotani, Magnus Edlund, Chia-Ling Hsieh, Ruoxiang Wang, Bahig Shehata, Haiyen E Zhau.   

Abstract

Cancer is not a single-cell disease, and its existence and behavior are constantly modulated by the host. Cancer gene expression and genetics are also highly dynamic and are regulated epigenetically by the host through gene-environment interaction. In this article, we describe the molecular pathways leading to an unusual property of cancer cells: the ability to mimic the host microenvironment and, in particular, the characteristics of osteomimicry and vasculogenic mimicry, which are likely to be regulated by soluble and insoluble factors in the tumor-adjacent microenvironment. We also discuss the importance of host inflammatory and stem cells that contribute to the growth and survival of cancer cells. By understanding the salient features of cancer-host interaction, novel therapeutics might be developed to target the cancer and its host in the treatment of lethal prostate cancer metastases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17026806     DOI: 10.3816/CGC.2006.n.034

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  33 in total

1.  β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.

Authors:  Sajni Josson; Takeo Nomura; Jen-Tai Lin; Wen-Chin Huang; Daqing Wu; Haiyen E Zhau; Majd Zayzafoon; M Neale Weizmann; Murali Gururajan; Leland W K Chung
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

2.  Identification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics.

Authors:  Young Ah Goo; Alvin Y Liu; Soyoung Ryu; Scott A Shaffer; Lars Malmström; Laura Page; Liem T Nguyen; Catalin E Doneanu; David R Goodlett
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

3.  The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.

Authors:  Jean C-Y Tien; Zhaoliang Liu; Lan Liao; Fen Wang; Yixiang Xu; Ye-Lin Wu; Niya Zhou; Michael Ittmann; Jianming Xu
Journal:  Cancer Res       Date:  2013-05-06       Impact factor: 12.701

4.  Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients.

Authors:  Qinlong Li; Quanlin Li; Jill Nuccio; Chunyan Liu; Peng Duan; Ruoxiang Wang; Lawrence W Jones; Leland W K Chung; Haiyen E Zhau
Journal:  Prostate       Date:  2015-05-19       Impact factor: 4.104

5.  Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism.

Authors:  Hongyun Zhao; Lifeng Yang; Joelle Baddour; Abhinav Achreja; Vincent Bernard; Tyler Moss; Juan C Marini; Thavisha Tudawe; Elena G Seviour; F Anthony San Lucas; Hector Alvarez; Sonal Gupta; Sourindra N Maiti; Laurence Cooper; Donna Peehl; Prahlad T Ram; Anirban Maitra; Deepak Nagrath
Journal:  Elife       Date:  2016-02-27       Impact factor: 8.140

6.  A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone.

Authors:  Parisa Hesami; Boris M Holzapfel; Anna Taubenberger; Martine Roudier; Ladan Fazli; Shirly Sieh; Laure Thibaudeau; Laura S Gregory; Dietmar W Hutmacher; Judith A Clements
Journal:  Clin Exp Metastasis       Date:  2014-02-08       Impact factor: 5.150

7.  Establishment and characterization of a prostate cancer cell line from a prostatectomy specimen for the study of cellular interaction.

Authors:  Ruoxiang Wang; Gina C-Y Chu; Xudong Wang; Jason B Wu; Peizhen Hu; Asha S Multani; Sen Pathak; Haiyen E Zhau; Leland W K Chung
Journal:  Int J Cancer       Date:  2019-05-10       Impact factor: 7.396

8.  In vitro and in vivo model systems used in prostate cancer research.

Authors:  David Cunningham; Zongbing You
Journal:  J Biol Methods       Date:  2015

9.  Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.

Authors:  Kayvan R Keshari; Renuka Sriram; Mark Van Criekinge; David M Wilson; Zhen J Wang; Daniel B Vigneron; Donna M Peehl; John Kurhanewicz
Journal:  Prostate       Date:  2013-03-26       Impact factor: 4.104

10.  Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.

Authors:  J E Bohonowych; U Gopal; J S Isaacs
Journal:  J Oncol       Date:  2010-06-24       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.